Financhill
Back

Zymeworks Vs. Spyre Therapeutics Industry Stock Comparison

Sell
50

ZYME
Zymeworks

Last Price:
8.54
Seasonality Move:
-8.54%
Sell
39

SYRE
Spyre Therapeutics

Last Price:
25.33
Seasonality Move:
49.76%
Sell
50
Zymeworks (ZYME) is a Sell

Is Zymeworks a Buy, Sell or Hold?

  • The current Zymeworks [ZYME] share price is $8.54. The Score for ZYME is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • ZYME is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Spyre Therapeutics (SYRE) is a Sell

Is Spyre Therapeutics a Buy, Sell or Hold?

  • The current Spyre Therapeutics [SYRE] share price is $25.43. The Score for SYRE is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • SYRE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ZYME Stock Price Chart

What is Zymeworks's stock price today?

  • The Zymeworks share price today is $8.54
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ZYME is experiencing selling pressure, which indicates risk of future bearish movement.

SYRE Stock Price Chart

What is Spyre Therapeutics's stock price today?

  • The Spyre Therapeutics share price today is $25.43
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SYRE is experiencing selling pressure, which indicates risk of future bearish movement.

ZYME Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0 Buy
Relative Strength Index (14 RSI): 42.38 Sell
Chaikin Money Flow: -333121 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.6 - 9.24) Sell
Bollinger Bands (100): (8.74 - 11.28) Sell

SYRE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.04 Sell
Relative Strength Index (14 RSI): 31.35 Sell
Chaikin Money Flow: -1780910 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.05 - 37.75) Sell
Bollinger Bands (100): (27.4 - 39.18) Sell

ZYME Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.1 Sell
20-day SMA: 8.85 Sell
50-day SMA: 8.91 Sell
200-day SMA: 9.08 Sell
8-day EMA: 8.97 Sell
20-day EMA: 8.94 Sell
50-day EMA: 9.14 Sell
200-day EMA: 9.26 Sell

SYRE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 33.63 Sell
20-day SMA: 34.16 Sell
50-day SMA: 35.1 Sell
200-day SMA: 24.22 Buy
8-day EMA: 32.34 Sell
20-day EMA: 33.91 Sell
50-day EMA: 34.32 Sell
200-day EMA: 27.18 Sell

Zymeworks Earnings Growth & ZYME Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, an increase next quarter of $0.02 per share, an increase this year of $0.89 per share, and a decrease next year of $0.42 per share.

Spyre Therapeutics Earnings Growth & SYRE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.10 per share, an increase this year of $9.41 per share, and an increase next year of $0.45 per share.

Zymeworks Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Spyre Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):